Getting your player ready...
INDIANAPOLIS — AstraZeneca will cut roughly 24 percent of its U.S. sales force in a push to curb costs as the drugmaker fends off growing generic challenges.
The British company said Wednesday it will cut 1,150 employees, including sales representatives and managers.
